SCHEMBL12608442

SCHEMBL12608442

CCCNC(=O)C(=O)[C@@H]1CCCCCCCCC[C@H](NC(=O)NC2(CS(=O)(=O)N(C)C)CCCCC2)C(=O)N2C[C@H]3[C@@H]([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12606751 1.00 — —
SCHEMBL12607479 1.00 — —
SCHEMBL8034350 1.00 — —
SCHEMBL12607506 0.94 — —
SCHEMBL12607514 0.93 — —
SCHEMBL12607977 0.92 — —
SCHEMBL12608059 0.92 — —
SCHEMBL12606747 0.92 — —
SCHEMBL12608013 0.91 — —
SCHEMBL12607499 0.91 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback